Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-25-000008

Chief Executive Officer returned 10,261 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virnich Daniel Chief Executive Officer 2025-03-19 Returned to the company −10,261 $0.89 $9,122 701,723 D
Loading xslF345X05/wk-form4_1742508091.xml…